The Lira Pump Trial. The Effects of Liraglutide in Patients With Insulin Pump Treated Type 1 Diabetes: A Randomized Placebo-Controlled Trial
Phase of Trial: Phase II/III
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Lira Pump
- 15 Sep 2017 Primary endpoint of change in HbA1c at 26 week has been met, according to results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 13 Jun 2017 Results assessing changes in insulin dosing patterns during the study, presented at the 77th Annual Scientific Sessions of the American Diabetes Association.